ALSO NOTED: Salix licenses product; FDA OKs new Depakote indication; States get poor grades on pandemic planning;and much more.

> Salix Pharmaceuticals has obtained the license for the experimental NRL944, a bowel cleaning product, for $37 million. Report

> The FDA has approved a new indication for Depakote ER. Release

> A new report gives more than half of US states a failing grade for their ability to handle a medical emergency like a pandemic. Delaware, South Carolina and Virginia scored the highest. Article

> Japan's BioWa has licensed cell-targeting technology to MedImmune in exchange for unspecified fees and milestone payments. Report

And Finally… Mini-clinics have been popping up in pharmacies around the country to dispense some quick diagnoses for what ails us. Article